Background
==========

In patients suffering from chronic liver diseases (CLDs), the necrosis of hepatocytes and the progression of inflammatory reaction cause liver fibrosis \[[@b1-medscimonit-22-1349]\]. Without timely and appropriate intervention, the liver fibrosis gradually progresses into cirrhosis, hepatocellular carcinoma (HCC), and, ultimately, liver failure \[[@b2-medscimonit-22-1349]\]. The staging, *i.e*., the classification and identification of stages or degree of liver fibrosis, is of major clinical concern, because it is the strongest prognostic indicator and crucial for the optimization of treatment strategies \[[@b3-medscimonit-22-1349]\].

Currently, liver biopsy (LB) is considered as the criterion standard to evaluate the degree of liver fibrosis \[[@b4-medscimonit-22-1349],[@b5-medscimonit-22-1349]\]. However, liver biopsy is an invasive method possibly causing pain, hemorrhage, and even mortality. Moreover, liver biopsy is susceptible to inter/intra-observer variability, sampling error, and other limits \[[@b6-medscimonit-22-1349]--[@b8-medscimonit-22-1349]\]. In the recent years, the advances in imaging technology have enabled quantitative and noninvasive measurements of liver stiffness with various ultrasound-based elastographic methods, including Real-time Tissue Elastography (RTE), Transient Elastography (TE) (Fibroscan; Echosense, Paris, France), Acoustic Radiation Force Impulse Imaging (ARFI; Siemens, Erlangen, Germany), and Real-time Shear Wave Elastography (SWE) (Aixplorer; Supersonic Imagine, Aix-en-Provence, France) \[[@b9-medscimonit-22-1349]--[@b13-medscimonit-22-1349]\]. Among these methods, SWE is a new real-time technique using measurements of acoustically generated tissue shear wave propagation velocity to derive the estimates of liver stiffness. SWE has the advantages of providing anatomic B-mode US images and elastographic color maps according to the degree of stiffness simultaneously, which offers the potential of enhanced accuracy in the assessment of liver stiffness \[[@b14-medscimonit-22-1349],[@b15-medscimonit-22-1349]\].

RTE, TE, and ARFI have been evaluated in several meta-analyses for their roles in staging liver fibrosis, and were shown to have clinically satisfactory high accuracy for the diagnosis of cirrhosis but intermediate accuracy for differentiating between mild and moderate liver fibrosis \[[@b16-medscimonit-22-1349]--[@b18-medscimonit-22-1349]\]. Although an increasing number of studies have evaluated the utility of SWE in assessing the degree of liver fibrosis, wide ranges of sensitivity and specificity were reported \[[@b12-medscimonit-22-1349],[@b14-medscimonit-22-1349],[@b15-medscimonit-22-1349],[@b19-medscimonit-22-1349]--[@b28-medscimonit-22-1349]\]. A systematic approach to this topic integrating the SWE data from independent studies may provide a better assessment of the utility of SWE in liver fibrosis staging. Therefore, we performed a meta-analysis to assess the overall performance of SWE in the diagnosis of liver fibrosis.

Material and Methods
====================

Search strategy
---------------

Relevant published studies present in the databases of MEDLINE, PubMed, Embase, and Google Scholar were searched using the following terms: (elastography OR shear wave elastography) AND (liver OR hepatic) AND (diagnosis OR diagnostic test). For each relevant published study thus identified, the references cited in the study were further scrutinized to obtain more related studies. Our analysis was performed in accordance with the PRISMA statement.

Study inclusion
---------------

To be included, the articles had to meet the following criteria. First, the articles assessed the effects of SWE in diagnosis of liver fibrosis stages with quantitative determination. Second, the diagnosis of liver fibrosis was confirmed using the liver biopsy as the criterion standard and the fibrosis stages were scored according to METAVIR or comparable staging systems. Third, the studies provided available data on true positive (TP), false positive (FP), false negative (FN), and true negative (TN) or reported sufficient data (sensitivity, specificity, negative predictive value \[NPV\] and positive predictive value \[PPV\]) to derive these parameters. Fourth, every study enrolled at least 30 patients. Fifth, if 2 or more publications came from the same primary study, the publication with larger the sample size was included.

The methodological quality of each article was evaluated by the Quality Assessment for Studies of Diagnostic Accuracy (QUADAS) tool ([Table 1](#t1-medscimonit-22-1349){ref-type="table"}).

Data extraction
---------------

Two investigators independently extracted the following data from each article using standardized forms: 1) name of first author; 2) year of publication; 3) country; 4) number of patients; 5) sex distribution; 6) mean age, 7) diagnosis of liver diseases; 8) SWE parameter; 9) measurement location; and 10) cut-off stage of fibrosis. Disagreements were resolved by discussion between the 2 investigators.

Statistical analysis
--------------------

According to the METAVIR scoring system, the hepatic fibrosis could be staged into 5 groups (F0, no fibrosis; F1, portal fibrosis without septa; F2, portal fibrosis and few septa, but intact architecture; F3, numerous septa, architectural distortion, but no obvious cirrhosis; and F4, cirrhosis). Our assessments of the diagnostic accuracy were made for the discrimination of F0 versus F1--4, F0/1 versus F2--4, F0--2 versus F3/4, and F0--3 versus F4. In this study, these discriminations were also described as F≥1, F≥2, F≥3, and F≥4, respectively. Based on this, the 2×2 contingency tables including TP, FP, TN, and FN results were established. The pooled sensitivity and specificity with corresponding 95% confidence intervals (CIs) were used to analyze the degree of accuracy of SWE in identifying the stages of liver fibrosis. The summary receiver operating characteristic (SROC) curve also was used to present the results. χ^2^ and I^2^ tests were calculated to evaluate the study heterogeneity. I^2^\>50% or *P*≤0.05 suggests the heterogeneity exists, and a random-effects model was applied in the analysis for the heterogenic data. Otherwise, the fixed-effects model was applied. The publication bias was assessed by Deeks funnel plot asymmetry test. Fagan plot analysis was also performed. Pre-test probabilities of 25%, 50%, and 75% were assumed. The corresponding post-test probabilities were calculated following a "positive" or "negative" result based on the summary sensitivity and specificity of SWE, which showed the relationship among the prior probability specified, the likelihood ratio, and posterior test probability \[[@b18-medscimonit-22-1349],[@b29-medscimonit-22-1349]\]. The meta-analysis was completed in Stata 12.0 (StataCorp., College Station, TX, USA).

Results
=======

Study characteristics
---------------------

A total of 405 published studies were retrieved using the search strategy described in the methods section. We excluded 350 articles for lack of relevance, based on inspecting the abstracts. Full texts of 55 articles were obtained for further evaluation. Then, 8 articles were selected in the meta-analysis \[[@b14-medscimonit-22-1349],[@b15-medscimonit-22-1349],[@b19-medscimonit-22-1349]--[@b22-medscimonit-22-1349],[@b26-medscimonit-22-1349],[@b27-medscimonit-22-1349]\] ([Figure 1](#f1-medscimonit-22-1349){ref-type="fig"}). The 8 published studies were performed in the United States, Italy, China, Korea, and Japan. There were 934 patients and their ages ranged from 12 to 82 years. Diseases etiology was categorized as hepatitis C virus (HCV), hepatitis B virus (HBV), and others. All the studies used the METAVIR scoring system. The adopted diagnosis parameter was E (Young's modulus) expressed in kPa. The features of the studies are shown in [Table 2](#t2-medscimonit-22-1349){ref-type="table"}. It should be mentioned that in the study conducted by Beland et al., the liver stiffness was measured in kPa on an ultrasound machine and converted to m/s by using the conversion formula \[[@b22-medscimonit-22-1349]\].

Summary estimates of sensitivity and specificity
------------------------------------------------

[Table 3](#t3-medscimonit-22-1349){ref-type="table"} shows the test results of SWE in identifying the stages of liver fibrosis: area under curve (AUC), cutoff values, sensitivity, and specificity. There was no study discriminating F0 versus F1--4. Therefore, the data for F≥1 were not synthesized.

The 8 studies all provided quantitative values for discriminating F0/1 versus F2--4. A total of 934 patients were included in the meta-analysis. The cutoff value ranged from 6.65--8.8 kPa. The pooled analysis indicated that the overall sensitivity and specificity were 85.0% (95% CI, 82--88%) and 81% (95% CI, 71--88%), respectively ([Figure 2](#f2-medscimonit-22-1349){ref-type="fig"}). The area under SROC curve with 95% CI was presented as 0.88 (95% CI, 0.85--0.91) ([Figure 3](#f3-medscimonit-22-1349){ref-type="fig"}).

The diagnostic accuracies of SWE for F≥3 and F≥4 were also evaluated. A total of 533 patients were included to analyze the test results of SWE for F≥3. The combined outcomes revealed the test sensitivity and specificity at 90.0% (95% CI, 83.0%--95.0%) and 81.0% (95% CI, 75.0--86.0%), respectively, for F≥3 ([Figure 2](#f2-medscimonit-22-1349){ref-type="fig"}). The corresponding area of SROC was 0.94 (95% CI, 0.92--0.96) ([Figure 3](#f3-medscimonit-22-1349){ref-type="fig"}). A total of 700 patients were included to analyze the test of SWE for the detection of liver cirrhosis (F≥4). The test sensitivity and specificity of SWE were 87.0% (95% CI, 80.0--92.0%) and 88.0% (95% CI, 80.0--93.0%) ([Figure 2](#f2-medscimonit-22-1349){ref-type="fig"}). The area of SROC was 0.92 (95% CI, 0.89--0.94) ([Figure 3](#f3-medscimonit-22-1349){ref-type="fig"}).

Study heterogeneity and publication bias
----------------------------------------

In the heterogeneity test, the sensitivity of F≥2 (I^2^=1.16%, P=0.42), specificity of F≥3 (I^2^=47.32%, P=0.13) and sensitivity of F≥4 (I^2^=15.48%, P=0.32) showed no heterogeneity, while there were heterogeneities for specificity of F≥2 (I^2^=86.43%, P\<0.01), sensitivity of F≥3 (I^2^=51.32%, P=0.10), and specificity of F≥4 (I^2^=78.05%, P\<0.01). Therefore, the sensitivity of F≥2, specificity of F≥3 and sensitivity of F≥4 were analyzed under the fixed-effects model, while specificity of F≥2, sensitivity of F≥3 and specificity of F≥4 were analyzed under the random-effects model. According to Deeks funnel plot asymmetry test, no publication bias was detected for the analysis of F≥2, F≥3 and F≥4 (P=0.924, 0.494 and 0.343) ([Figure 4](#f4-medscimonit-22-1349){ref-type="fig"}).

Fagan plot analysis
-------------------

The Fagan plot demonstrated that when the pre-test probabilities were 25% or 50% or 75%, the positive post-probabilities of significant fibrosis (F≥2) were 60%, 82% and 93%, and the negative post-probabilities were 6%, 15% and 35%, respectively ([Figure 5](#f5-medscimonit-22-1349){ref-type="fig"}). For F≥3, when the pre-test probabilities were 25% or 50% or 75%, the positive post-probabilities were 61%, 83%, and 93%, and the negative post-probabilities were 4%, 11%, and 26%, respectively ([Figure 5](#f5-medscimonit-22-1349){ref-type="fig"}). For F≥4, when the pre-test probabilities was 25% or 50% or 75%, the positive post-probabilities were 70%, 88%, and 96%, and the negative post-probabilities were 5%, 13%, and 31%, respectively ([Figure 5](#f5-medscimonit-22-1349){ref-type="fig"}).

Discussion
==========

SWE, a novel ultrasound-based technique, differs from conventional elastography in which the radiation force is produced by ultrasonic beam to induce the mechanical vibrations automatically. The reliability and reproducibility of SWE does not depend on the sonographer's ability to stress or vibrate tissue correctly. Based on the ultrafast sonographic tracking techniques and the Young's modulus formula, the quantitative information could be delivered as an elasticity index expressed in kilopascals, and real-time elastographic color maps can be displayed, showing stiffer tissue in red and softer tissue in blue. Therefore, SWE could quantify tissue stiffness directly and can be considered as a diagnostic tool that might compensate the limitations of RTE, TE and ARFI \[[@b30-medscimonit-22-1349]\].

In this meta-analysis, we evaluated the performance of SWE for the assessment of liver stiffness. To the best of our knowledge, this is the first meta-analysis on this topic. Through systematic literature search and screening process, 8 studies assessing the performance of SWE in the diagnosis of liver fibrosis satisfied the inclusion criteria. Sufficient elastographic data including the quantitative stiffness information expressed in kPa could be extracted from these studies to perform a meta-analysis. The results of our meta-analysis indicate that SWE has high diagnostic accuracy in diagnosing F≥3 (sensitivity 90%, specificity 81%), F≥4 (sensitivity 87%, specificity 88%) and relatively high accuracy in F≥2 (sensitivity 85%, specificity 81%). For any cut-off stage of the liver fibrosis, both summary specificity and sensitivity are above 80%. It should be noted that our included studies used patients who underwent liver biopsy with various liver diseases. According to Tsochatzis et al., different etiologies of liver disease might have different stiffness cut-offs for a given fibrosis stage \[[@b31-medscimonit-22-1349]\]. Nierhoff et al. conducted a meta-analysis to explore the efficiency of ARFI for the staging of liver fibrosis. They reported that there was a slight trend towards higher diagnostic accuracy in studies with patients only infected with HCV than in studies with patients with different liver diseases. Further subgroup analyses showed a significantly better diagnostic accuracy for the diagnosis of severe fibrosis for the studies without HBV-infected patients than for those including HBV-infected patients. Moreover, given that patients who underwent liver biopsy represent a population biased towards more severe liver diseases, the conclusion from the current study may find more validity among patients with more severe liver diseases than those with mild liver diseases.

The majority of our included studies chose the right lobe as the measurement location. Samir et al. found that the SWE Young modulus of upper right lobe showed the highest correlation with fibrosis stage \[[@b14-medscimonit-22-1349]\]. When compared with the results of meta-analyses on RTE, ARFI, and TE, the pooled sensitivity and specificity of SWE (87%, 88%) seems to be similar for the diagnosis of cirrhosis (F≥4). The pooled sensitivity and specificity of RTE, ARFI, and TE were 74% and 84%, 87% and 87%, 83% and 89%, respectively. But for the diagnosis of significant fibrosis (F2), the overall accuracy of SWE is higher than that of TE and RTE, and nearly identical with ARFI. For TE and RTE, the summary sensitivities were both reported as 79% and the specificities were 78% and 76% respectively, while for ARFI, the pooled sensitivity was reported as 74% and specificity was 83% \[[@b32-medscimonit-22-1349]--[@b34-medscimonit-22-1349]\]. Differentiating significant fibrosis (F2--4) from non-significant fibrosis (F0 and F1) has considerable clinical significance for patients with CLDs, especially for the HCV patients because significant fibrosis (F≥2) at the time of diagnosis has been shown to correlate with long-term cirrhosis risk \[[@b35-medscimonit-22-1349],[@b36-medscimonit-22-1349]\]. In this regard, SWE may fill an important void. Furthermore, the elastographic techniques, such as ARFI and TE, have some common limitations. The influence of hepatic inflammation and steatosis on the tissue stiffness is still a matter of debate. According to Rizzo et al., ARFI was not associated with alanine transaminase (ALT) or liver steatosis, while TE was significantly correlated with the ALT value. However, Bota et al. reported that at least 2 stages of liver fibrosis between ARFI results and histologic assessment were associated \[[@b37-medscimonit-22-1349]--[@b39-medscimonit-22-1349]\]. In the study of Samir et al., the authors rejected the effect of inflammation or steatosis on the fibrosis estimation with the use of SWE \[[@b14-medscimonit-22-1349]\].

The overall results suggested that SWE has high accuracy in diagnosing F≥3 (sensitivity 90%, specificity 81%), F≥4 (sensitivity 87%, specificity 88%), and moderate accuracy in diagnosing F≥2 (sensitivity 85%, specificity 81%). It is also essential to know that test utility varies with disease perceived risk. Therefore, Fagan plot analysis was performed in this study. In the stage of F≥2, when the pre-test probability is 75%, 93% of the patients following "positive" results could be correctly diagnosed. However, when the pre-test probability -- is 25%, there is only 60% probability of correctly diagnosing F≥2 with a "positive" result. Similarly, for the stage of F≥3, when the pre-test probability changes from 75% to 25%, the post-test probability accordingly decreases from 93% to 61%. Finally, for F≥4, the post-test probability decreases from 96% to 70%. This analysis indicates that for the staging of liver fibrosis in the low-risk population, SWE still lack appropriate accuracy.

Our study has several limitations. Firstly, we only identify 8 eligible studies that met the inclusion criteria. This may be due to the fact that SWE is still a new technique and large-scale studies are required to validate the clinical use of SWE in staging of liver fibrosis. Furthermore, we could not perform subgroup analyses for various liver diseases such as HCV because of the limited number of studies. In addition, our results were generated from different etiological groups within the same analysis. It is known that the relationship between the progression of liver fibrosis and the liver elasticity varies depending on the underlying liver disease. Therefore, in future studies we encourage the researchers to be more rigorous in patient selection.

Conclusions
===========

Our meta-analysis demonstrates that for the staging of liver fibrosis, the overall accuracy of SWE is good. Compared with the results of meta-analyses on RTE, TE, and ARFI, the performance of SWE seems to be nearly identical for the evaluation of cirrhosis. For the evaluation of significant liver fibrosis (F≥2), the overall accuracy of SWE seems to be similar to ARFI, but higher than RTE and TE. However, the conclusion is made just from the data described in this article and some meta-analyses on other elastographic techniques. Large-scale, well-designed, and multi-center studies are needed to validate the conclusion and further evaluate the potential of SWE.

**Source of support:** Departmental sources
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###### 

Quality assessment of included sutdies.

  Author, year             Q1    Q2    Q3    Q4        Q5    Q6    Q7    Q8    Q9    Q10       Q11       Q12   Q13   Q14   QUADAS score
  ------------------------ ----- ----- ----- --------- ----- ----- ----- ----- ----- --------- --------- ----- ----- ----- --------------
  Beland et al., 2014      Yes   Yes   Yes   Yes       Yes   Yes   Yes   Yes   Yes   Yes       Yes       Yes   Yes   Yes   14
  Ferraioli et al., 2012   Yes   Yes   Yes   Yes       Yes   Yes   Yes   Yes   Yes   Yes       Yes       Yes   Yes   Yes   14
  Zeng et al., 2014        Yes   Yes   Yes   Yes       Yes   Yes   Yes   Yes   Yes   Yes       Yes       Yes   Yes   Yes   14
  Yoon et al., 2014        Yes   Yes   Yes   Unclear   Yes   Yes   Yes   Yes   Yes   Unclear   Yes       Yes   Yes   Yes   12
  Jeong et al., 2014       Yes   Yes   Yes   Unclear   Yes   Yes   Yes   Yes   Yes   Yes       Unclear   Yes   Yes   Yes   12
  Samir et al., 2014       Yes   Yes   Yes   Yes       Yes   Yes   Yes   Yes   Yes   Yes       Yes       Yes   Yes   Yes   14
  Zheng et al., 2015       Yes   Yes   Yes   Yes       Yes   Yes   Yes   Yes   Yes   Yes       Yes       Yes   Yes   Yes   14
  Tada et al., 2015        Yes   Yes   Yes   Unclear   Yes   Yes   Yes   Yes   Yes   Yes       Yes       Yes   Yes   Yes   13

###### 

Characteristics of studies evaluating the performance of SWE for staging of liver fibrosis.

  Study                                                          Age      Sample size   Male, n   Disease spectrum   Detection position     Cut-off stage of fibrosis
  -------------------------------------------------------------- -------- ------------- --------- ------------------ ---------------------- ---------------------------
  Beland et al. 2014 (America) \[[@b20-medscimonit-22-1349]\]    21--72   50            25        HCV, others        The biopsy site        F≥2
  Ferraioli et al. 2012 (Italy) \[[@b17-medscimonit-22-1349]\]   19--76   121           87        HCV                The right lobe         F≥2, F≥3, F≥4
  Zeng et al. 2014 (China) \[[@b18-medscimonit-22-1349]\]        20--59   206           167       HBV                The right lobe         F≥2, F≥3, F≥4
  Yoon et al. 2014 (Korea) \[[@b19-medscimonit-22-1349]\]        18--75   129           87        HBV, HCV, others   The right lobe         F≥2
  Jeong et al. 2014 (Korea) \[[@b13-medscimonit-22-1349]\]       12--82   70            32        HBV, HCV, others   The right lobe         F≥2, F≥3, F≥4
  Samir et al. 2014 (America) \[[@b12-medscimonit-22-1349]\]     18--74   136           70        HCV, others        The right upper lobe   F≥2, F≥3, F≥4
  Zheng et al. 2015 (China) \[[@b24-medscimonit-22-1349]\]       18--67   167           119       HBV, HCV, others   The right lobe         F≥2, F≥4
  Tada et al. 2015 (Japan) \[[@b25-medscimonit-22-1349]\]        24--78   55            23        HCV                The right lobe         F≥2

HCV -- hepatitis C virus; HBV -- hepatitis B virus.

###### 

The test results of SWE in detecting the stages of liver fibrosis.

  Study                                                  Diagnosis parameter   Fibrosis F≥2   Fibrosis F≥3   Fibrosis F≥4                                                             
  ------------------------------------------------------ --------------------- -------------- -------------- -------------- ----------- ------------- ------- ---------- ------------ -------
  Beland et al. 2014 \[[@b20-medscimonit-22-1349]\]      SWV                   1.87 m/s       75/75          0.82           NA          NA/NA         NA      NA         NA/NA        NA
  Ferraioli et al. 2012 \[[@b17-medscimonit-22-1349]\]   E                     7.1 kPa        90/87.5        0.92           8.7 kPa     97.3/95.1     0.98    10.4 kPa   87.5/96.8    0.98
  Zeng et al. 2014 \[[@b18-medscimonit-22-1349]\]        E                     7.2 kPa        86.36/86.96    0.917          9.1 kPa     91.94/85.71   0.945   11.7 kPa   91.89/89.7   0.945
  Yoon et al. 2014 \[[@b19-medscimonit-22-1349]\]        E                     6.65 kPa       78.8/75.6      0.852          NA          NA/NA         NA      NA         NA/NA        NA
  Jeong et al. 2014 \[[@b13-medscimonit-22-1349]\]       E                     8.6 kPa        78.2/93.3      0.915          10.46 kPa   88.6/80       0.913   14 kPa     77.3/85.4    0.878
  Samir et al. 2014 \[[@b12-medscimonit-22-1349]\]       E                     7.29 kPa       91.4/52.5      0.77           8.9 kPa     76.5/76.5     0.82    9.59 kPa   71.4/82.2    0.82
  Zheng et al. 2015 \[[@b24-medscimonit-22-1349]\]       E                     NA             85.7/73.9      0.86           NA          NA/NA         NA      NA         91.2/79.7    0.93
  Tada et al. 2015 \[[@b25-medscimonit-22-1349]\]        E                     8.8 kPa        88.9/91.9      0.94           NA          NA/NA         NA      NA         NA/NA        NA

Note: SWV, shear wave velocity; E, Young's modulus.
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